Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

A new study published in the Journal of American Medical Association showed that Guselkumab was highly effective and durable ...

These data indicate that "prolonged [TNF inhibitor] treatment plays a protective role in PsA development in severe psoriasis ...

How Does Psoriasis Increase Your Risk of Developing Other Conditions? Psoriasis is much more than a skin condition. Though it ...

This segment is sponsored by Arcutis Biotherapeutics.Nearly 9 million people in the U.S. have an inflammatory skin condition ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

How to tell if you have psoriasis or ringworm as these two skin conditions look similar but need completely different ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...